Suppression of DNA-PKcs enhances FGF-2 dependent human endothelial cell proliferation via negative regulation of Akt

Cell Signal. 2010 Jan;22(1):88-96. doi: 10.1016/j.cellsig.2009.09.015. Epub 2009 Sep 23.

Abstract

Angiogenesis initiation is crucially dependent on endothelial proliferation and can be stimulated by the fibroblast growth factor 2 (FGF-2). The DNA dependent protein kinase (DNA-PK), long known for its importance in repairing DNA double strand breaks, belongs to the phosphatidylinositol-3 kinase (PI3-K) super family and has recently been identified as one of the enzymes phosphorylating and activating Akt. Due to its similarity with PI3-K, we hypothesized that DNA-PK may have similar effects on endothelial angiogenic processes and signalling. We used primary endothelial cells (HUVEC and PAEC) and human microvascular endothelial cells (HMEC) to study the role of DNA-PK in endothelial proliferation and signalling. DNA-PKcs suppression with the compound NU7026 or with siRNA induced basal endothelial cell proliferation as well as enhanced FGF-2 dependent proliferation. This was associated with an increase in phosphorylated Akt. Tube formation was not affected by DNA-PKcs clearly showing that the role of DNA-PK in endothelial processes differs from that of PI3-K. Our findings indicate DNA-PK as an important enzyme maintaining the quiescent endothelial phenotype by actively inhibiting Akt thus restraining endothelial cell proliferation preventing excessive growth.

MeSH terms

  • Cell Proliferation* / drug effects
  • Cells, Cultured
  • Chromones / pharmacology
  • DNA-Activated Protein Kinase / antagonists & inhibitors
  • DNA-Activated Protein Kinase / genetics
  • DNA-Activated Protein Kinase / metabolism*
  • Endothelial Cells / cytology*
  • Endothelial Cells / metabolism*
  • Fibroblast Growth Factor 2 / metabolism*
  • Humans
  • Morpholines / pharmacology
  • Nuclear Proteins / antagonists & inhibitors
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism*
  • Phosphoserine / metabolism
  • Protein Kinase Inhibitors / pharmacology
  • Proto-Oncogene Proteins c-akt / metabolism*
  • RNA, Small Interfering / genetics

Substances

  • 2-(morpholin-4-yl)benzo(h)chromen-4-one
  • Chromones
  • Morpholines
  • Nuclear Proteins
  • Protein Kinase Inhibitors
  • RNA, Small Interfering
  • Fibroblast Growth Factor 2
  • Phosphoserine
  • DNA-Activated Protein Kinase
  • PRKDC protein, human
  • Proto-Oncogene Proteins c-akt